BIOL MISC 6630 quiz week 3 80 percent score exam 2022

BIOL MISC 6630 quiz week 3 80 percent score exam 2022 QUESTION 2 1. Which of the following consists of all the known major neurotransmitters that are relevant in psychiatry? A glutamate, GABA, dopamine, serotonin, norepinephrine, histamine, steroids, nitric . oxide B glutamate, GABA, dopamine, norepinephrine, serotonin, acetylcholine, histamine, . endogenous opioids, steroids, cannabinoids, nitric oxide C glutamate, GABA, dopamine, serotonin, acetylcholine, endogenous opioids, nitric . oxide, cannabinoids, steroids D glutamate, GABA, dopamine, serotonin, norepinephrine, endogenous opioids, . steroids, histamine, nitric oxide 3.75 points QUESTION 3 1. Upon blocking a Serotonin reuptake pump, what happens in the synaptic cleft and on the post synaptic cell membrane? A The result will be an increase in available Serotonin in the synaptic cleft causing the . post synaptic cell to increase the number of Serotonin receptors. B The result will be an increase in the available Serotonin in the synaptic cleft causing . the post synaptic neuron to reduce the number of Serotonin receptors. C The result will be an increase in Serotonin in the synaptic cleft resulting in an . increase in reuptake pumps on the presynaptic neuron. D The result will be an increase in Serotonin in the synaptic cleft resulting in a decrease . in reuptake pumps on the pre-synaptic neuron. 3.75 points QUESTION 4 A . I only B . III only C I, II, and V . only D . I, II, III, IV, and V E. I, III, and IV 3.75 points QUESTION 5 1. Of the components of patient-focused interventions to enhance adherence, which component includes the following strategies: adaptive thinking, use of cues, and support? A Motivati . on B Skills . C Logistics . D Educatio . n 3.75 points QUESTION 6 1. If a patient admits to taking his medication every other day (instead of daily, as prescribed), a potential concern would be: A Sufficient understanding or acceptance of . the illness B Abuse of the medication . C Expense . This study source was downloaded by from CourseH on :32:24 GMT -05:00 D Is the desired effect recognized at a lower . daily dose? A Slow effector pathways/G-protein . coupled receptor B Slow effector pathway/ion channel . C Rapid effector pathways/G-protein . coupled receptor D Rapid effector pathway/ion channel . QUESTION 8 1. Neurotransmitters are defined by four essential characteristics. These are: A Neurotransmitters are synthesized within presynaptic neurons. . B Depolarization of a neuron results in the release of a neurotransmitter, which exerts a . multitude of actions on the postsynaptic neuron. C Their action on postsynaptic neurons can be replicated by administering a drug that . mimics the activity of the endogenous neurotransmitter. D Their action in the synaptic cleft is terminated by a specific action. . E. A, C, and D only QUESTION 9 1. G-protein coupled receptors are examples of what type of effector pathway? A Slow effector pathways . B Rapid effector pathways . C NMDA glutamate receptor . pathways D Modulated effector pathways . QUESTION 10 1. Motivation is a component of patient-focused interventions to enhance adherence. Based on the transtheoretical model, readiness to change can fluctuate across five stages. Which stage is represented by the patient who is aware that a problem exists and, while seriously thinking about overcoming it, has not yet committed to a plan of action? A Preparation . B Action . C Contemplat . ion D Maintenanc . e QUESTION 11 1. Receptors trigger one of two effector pathways resulting in changes in neuronal activity. These changes will, ultimately, effect gene expression. Which effector pathway is characterized by ion flux through transmitter-activated channels resulting in an altered membrane potential and neuronal activity? A Slow effector pathways . B Modulated effector pathways . C Rapid effector pathways . D NMDA glutamate receptor . pathways QUESTION 12 1. When dopamine (subtype 2) receptors are blocked in this pathway (system), it is evident by EPS. A Mesocortical . B Tuberoinfundib . ular C Nigrostriatal . D Mesolimbic . The synaptic cleft is the space between a single neuron’s dendrites and axon A terminals in which intracellular communication occurs through the release of . neurotransmitters allowing for signal conduction throughout the central nervous system. B The synaptic cleft is the space between the cell body and axon terminals that allows for release of neurotransmitters from the presynaptic neuron for intercellular communication with an adjacent neuron (post synaptic neuron). The synaptic cleft is an area where dendrites and axon terminals are within close C proximity, allowing for the release of a neurotransmitter from a presynaptic neuron . that can interact with receptors on dendritic cells of a post synaptic neuron, which is the main basis for intercellular communication of neurons. 3.75 points QUESTION 14 1. Treatment adherence is affected by several different factors. Clinical factors include mood, anxiety, psychosis, and substance misuse. There are also patient factors such as knowledge, attitude, and beliefs; economic and racial/ethnic disparities, and clinical encounters. A patient who presents hopeless, with decreased energy, and poor concentration is affected by which factor? A Substance misuse . B Knowledge deficits